Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 2/20 | 0.34 |
| ▸ | RET | P07949 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16465881 | 1.00 | DPP4 (0.47) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL14235248 | 1.00 | DPP4 (0.47) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL31079055 | 0.90 | CTSK (0.44) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL6429049 | 0.86 | GRIN2B (0.41) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL22983925 | 0.84 | GRIN2B (0.40) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL25181626 | 0.84 | GRIN2B (0.40) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL22983926 | 0.84 | GRIN2B (0.40) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL25171334 | 0.82 | GRIN2B (0.41) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL25181160 | 0.82 | GRIN2B (0.41) | DPP4CTSKGRIN2BGRIN2CMEN1 | |
| SCHEMBL25171336 | 0.82 | GRIN2B (0.41) | DPP4CTSKGRIN2BGRIN2CMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104918615-B | The method for treating hepatopathy | 扎夫根股份有限公司 | 2018-10-12 | — | — | CN | disclosed |
| CN-103764641-B | The tricyclic compound of fractional saturation and preparation and application thereof | 扎夫根股份有限公司 | 2016-10-26 | — | — | CN | disclosed |
| CN-104918615-A | Methods of treating liver diseases | ZAFGEN INC | 2015-09-16 | — | — | CN | disclosed |